Постинсультная депрессия: научно обоснованные подходы к выбору терапии
https://doi.org/10.14412/2074-2711-2012-374
Аннотация
Ключевые слова
Список литературы
1. <div><p>Murray et al. WHO global health statistics, 1996.</p><p>Capaldi V.F., Wynn G.H. Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients. Psychol Res Behav Manag 2010;3:109-18.</p><p>Каннер А.М. Депрессия при неврологических заболеваниях. М.: Литтерра, 2007;159 с.</p><p>Ramasubbu R. Therapy for prevention of post-stroke depression. Exp opin Pharmacoter 2011;12(14):2177—87.</p><p>Вознесенская Т.Г. Депрессия при цереброваскулярных заболеваниях. Неврол нейропсихиатр психосом 2009;2:9-13.</p><p>Alexopoulos G.S., Meyers B.S., Young R.C. Vascular depression hypothesis. Arch Gen Psychiatry 1997;54:915-22.</p><p>Katon W.J. Clinical and health services relationship between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:21-6.</p><p>Lökk J., Delbar А. Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat 2010;6:539-49.</p><p>Whyte E.M., Mulsant B.H. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002;52(3):253—64.</p><p>Berg A., Palomaki H. Poststroke depression. An 18-monthfollow-up. Stroke 2003,34:138—43.</p><p>Morris P.L.P., Robinson R.G., Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med 1990;20:349—64.</p><p>Hackett M., Anderson C. Treatment options for post-stroke depression in the elderly. Aging Health 2005;1(1):95—105.</p><p>Cummings J.L., Mega J.L. Disturbances of mood and affect: cerebrovascular disease. In: J.L. Cummings, J.L. Mega. Neuropsychiatry and behavioral neuroscience. New York, NY: Oxford University Press, 2003;206.</p><p>Starkstein S.E., Robinson R.G., Berther M.L. et al. Depressive disorders following posterior circulation as compared with middle cerebral artery infarcts. Brain 1988;11:375—87.</p><p>Chemerinski E., Robinson R.G. The neuropsychiatry of stroke. Psychosomatics 2000;41(1):5—14.</p><p>Lyness J.M. The cerebrovascular model of depression in late life. CNS Spectr 2002;7(10):712—5.</p><p>Turner-Stokes L., Hassan N. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives. Clin Rehabil 2002;16(3):248—60.</p><p>Aben I., Verhey F., Lousberg R. et al. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics 2002;43(5):386—93.</p><p>Chemerinski E., Robinson R.G., Kosier J.T. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 2001;32(1):113—7.</p><p>House A., Dennis M., Hawton K. et al. Methods of identifying mood disorders in stroke patients: experience in the Oxfordshire community stroke project. Age Ageing 1989;18(6):371—9.</p><p>Banasr M., Duman R.S. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets 2007;6:311—20.</p><p>Li Y., Luikari B.W., Birnbaum S. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008;59:399—412.</p><p>Palomäki H., Kaste M., Berg A. et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 1999;66:490—4.</p><p>Jorge R.E., Robinson R.G., Arndt S. et al. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003;160:1823—9.</p><p>Robinson R.G., Jorge R.E., Moser D.J. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299(20):2391—400.</p><p>Hemeryck A., Belpaire F.M. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 2002;3(1):13—37.</p><p>Cipriani A., Furukawa T.A., Salanti G. et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373(9665):746—58.</p><p>Choi-Kwon S., Han S.W., Kwon S.U. et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006;37(1):156—61.</p><p>Murray V., von Arbin M., Bartfai A. et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 2005;66(6):708—16.</p><p>Fruehwald S., Gatterbauer E., Rehak P. et al. Early fluoxetine treatment of poststroke depression-a three-month doubleblind placebo-controlled study with an open-label long-term follow up. J Neurol 2003;250(3):347—51.</p><p>Rasmussen A., Lunde M., Poulsen D.L. et al. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003;44(3):216—21.</p><p>Andersen G., Vestergaard K., Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25:1099—104.</p><p>Jorge R.E., Acion L., Moser D. et al. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010;67(2):187—96.</p></div><br />
Рецензия
Для цитирования:
Starchina YA. Постинсультная депрессия: научно обоснованные подходы к выбору терапии. Неврология, нейропсихиатрия, психосоматика. 2012;4(1):116-120. https://doi.org/10.14412/2074-2711-2012-374
For citation:
Starchina YA. Post-stroke depression: scientifically substantiated approaches to choosing therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;4(1):116-120. (In Russ.) https://doi.org/10.14412/2074-2711-2012-374